Business & Finance14 January 2025, 2:12 pm 1 minute
Reuters was two-and-a-half minutes ahead of rivals on Eli Lilly’s unscheduled trading update, which showed fourth-quarter sales of its weight-loss drug Zepbound would miss Wall Street estimates. The drugmaker’s shares slumped 8% on the news.
Article TagsTopics of Interest: Business & FinanceType: Reuters BestSectors: Business & FinanceRegions: AmericasWin Types: SpeedStory Types: Exclusive / ScoopMedia Types: TextCustomer Impact: Important Regional Story
Winta ZesuAn investigation from BBC social media investigations correspondent Marianna Spring found some users on X were being paid "thousands of dollars" by the...
Last Updated:December 10, 2024, 18:02 ISTLG Electronics India IPO: LG Electronics India aims to enhance its public market presence and strengthen its financial position.The...
Google recently introduced its latest quantum chip, named Willow, marking a groundbreaking development in quantum computing. This chip demonstrates exceptional computational abilities, showcasing its...
Raamdeo Agrawal said that the current market is ideal for stock selection due to valuations and earnings decline. (AI image) Raamdeo Agrawal, chairman...